DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Roche Molecular Systems, Inc. 

4300 Hacienda Drive

Pleasanton  California  94588  U.S.A.
Phone: 925-730-8000 Fax: 925-225-0479


SEARCH JOBS

View Clinical Trials from BioPharm Insight

Roche Molecular Diagnostics (operating in the US as Roche Molecular Systems) develops, manufactures and supplies a wide array of innovative medical diagnostic products, services, tests, platforms and technologies. With its broad portfolio of oncology, virology, microbiology and blood screening tests, RMD’s clients include researchers, physicians, patients, hospitals, laboratories and blood banks around the world.

The business, headquartered in Pleasanton, California, was founded in the early 1990s following the acquisition of the revolutionary, Nobel-prize winning Polymerase Chain Reaction Technology (PCR). PCR quickly replicates a single specific fragment of DNA or RNA to quantities sufficient for accurate laboratory analysis.

Roche Molecular Diagnostics is a business area of Roche Diagnostics (Basel, Switzerland) that employs around 1,000 people across three locations: Pleasanton, California; Branchburg, NJ; and Rotkreuz, Switzerland.

Centers of Excellence for Roche Molecular Systems

Branchburg (US): The largest polymerase chain reaction (PCR) manufacturing site in the world, supply chain, global customer support and quality

Pleasanton (US):: Headquarters, R&D, regulatory, clinical and medical affairs, business marketing and strategic marketing support

Rotkreuz (CH): Development and production of systems (instruments) and lab network solutions (software)


 Key Statistics


Email:
Ownership: Subsidiary

Web Site: Roche Molecular Systems, Inc.
Employees: Approximately 1,100
Symbol: RHHBF.PK
 









 Company News
Roche Molecular Systems, Inc. (RHHBF.PK) Wins FDA Approval For First Ever Pap Alternative To Detect Cervical Cancer 4/24/2014 2:26:37 PM
AdvanDx, Inc. Elects Former Roche Molecular Systems, Inc. (RHHBF.PK) CEO, Heiner Dreismann, Ph.D., to Its Board of Directors 3/27/2013 10:58:50 AM
Roche Molecular Systems, Inc. (RHHBF.PK) Launches Redesigned Website 12/9/2011 5:00:11 PM
Roche Molecular Systems, Inc. (RHHBF.PK) Release: Blood Screening Test That Offers Immediate Viral Discrimination for Three Major Viruses Receives CE Mark 12/9/2011 4:48:28 PM
Roche Molecular Systems, Inc. (RHHBF.PK) Release: Companion Diagnostic Test That Identifies Patients With Melanoma Tumor Mutation Available in Europe 12/9/2011 4:41:54 PM
ATHENA Data Presented at International Papillomavirus Conference Support Use of Roche Molecular Systems, Inc. (RHHBF.PK)’s cobas® HPV Test in Primary Screening for Cervical Cancer 12/9/2011 4:40:13 PM
Roche (RHHBY)'s KRAS Diagnostic Test That Assists With Personalized Treatment of Colorectal Cancer Receives CE Mark 7/22/2011 7:47:01 AM
Pivotal Study Validates Roche (RHHBY)'s cobas(R) HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer 2/25/2011 7:38:31 AM
Roche (RHHBY) Release: First Duplex Test for Parvovirus B19 and Hepatitis A Virus Now Available in the US 2/4/2011 9:05:07 AM
Roche Molecular Systems, Inc. (RHHBF.PK) and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer 10/11/2010 6:47:21 AM
1234